As Australia faces a turning point in obesity management, researchers from Monash University have contributed new insights into the rapidly evolving use of glucagon-like peptide-1 receptor agonists ...

Obesity is often seen as a failure of willpower, but is, in fact, a disease: one caused by everything from socioeconomic conditions and family history to metabolic factors. For the 42% of US ...

But the use of GLP-1 agonists has changed how people and their health care providers approach weight management. In this webinar, you’ll learn about GLP-1 agonists that can help with obesity ...

A new study aimed at understanding perceptions of obesity management and the use of anti-obesity medicine by employers and employees in the U.S. is published in the peer-reviewed journal ...

The introduction to the issue notes the emergence of gastroenterology as a “major hub” for obesity management, according to a June 5 news release from the American College of Gastroenterology. Obesity ...